Federal health regulators say they are adding labeling to Yaz and other newer pills, emphasizing the drugs may be more likely to cause blood clots. That's compared to older contraceptive pills.
The new labeling will apply to medications that contain the manmade hormone drospirenone.
The FDA says the new labeling will detail recent studies suggesting the pills carry a slightly higher risk of blood clots, but that is still very rare.